
From Pharma to AGI Hype, and Developing AI in Finance: Martin Shkreli’s Journey
Gradient Dissent: Conversations on AI
00:00
Navigating Pharma: A Personal Journey
This chapter chronicles the speaker's unconventional journey in the biopharmaceutical industry, detailing their transition from controversial practices to investment strategies. It emphasizes the complexities of drug development and the unique insights gained through hands-on experiences and personal interactions in the industry.
Transcript
Play full episode